Pharmacogenomics (journal)

*Pharmacogenomics*
Discipline	Pharmacogenomics
Language	English
Edited by	David Gurwitz, Howard McLeod, Munir Pirmohamed
Publication details
History	2000–present
Publisher	Future Medicine Ltd
Frequency	18/year
Impact factor	2.350 (2016)
Standard abbreviations;
ISO 4	Pharmacogenomics
Indexing
CODEN	PARMFL
ISSN	1462-2416 (print); 1744-8042 (web);
OCLC no.	55059877
Links
	Journal homepage;

Pharmacogenomics is a peer-reviewed medical journal established in 2000 and published by Future Medicine. The editors-in-chief are David Gurwitz (Tel-Aviv University), Howard McLeod (University of North Carolina at Chapel Hill), and Munir Pirmohamed (University of Liverpool). The journal covers the field of pharmacogenomics.

Abstracting and indexing

The journal is abstracted and indexed in Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.350, ranking it 132nd out of 256 journals in the category "Pharmacology & Pharmacy".[1]

gollark: * about two megabtres

gollark: You could just use the ones you actually want to use then shove a megabyte of garbage data on the end.

gollark: That would make it very easy.

gollark: Oh, so also ones which aren't assigned.

gollark: Doesn't that include the private use ones?

"Journals Ranked by Impact: Pharmacology & Pharmacy". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.